Nachrichten zur GSK PLC Aktie

GSK trial shows promising results for treatment of persistent itch in rare liver disease

GSK PLC (LSE:GSK, NYSE:GSK)has reported positive results from its phase III trial of linerixibat, a drug being tested to treat…

ANALYSE-FLASH: Deutsche Bank Research senkt GSK auf 'Hold' - Ziel 1350 Pence

FRANKFURT (dpa-AFX Broker) - Deutsche Bank Research hat GSK von "Buy" auf "Hold" abgestuft und…

Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK

Almost £7 billion was wiped from the combined market values of GSK PLC and AstraZeneca PLC on Friday after Donald Trump unveiled his…

GSK going nowhere while key vaccines struggle, says US bank

GSK PLC (LSE:GSK, NYSE:GSK) looks undervalued, but the problem is that there is nothing on the horizon to change that perception…

GSK Aktie: Story nicht wesentlich verändert

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…

GSK Aktie: Pipeline-Updates abwarten - Guggenheim senkt das Rating

New York (www.aktiencheck.de) - GSK-Aktienanalyse von Guggenheim Securities: Aktuelle Bewertung Guggenheim-Analyst, Seamus Fernandez, hat GSK plc (ISIN: GB00BN7SWP63, WKN: A3DMB5, Ticker-Symbol: GS71,…

Vergleich für Medikament Zantac überschattet Quartal beim Pharmakonzern GSK

LONDON (dpa-AFX) - Der Milliardenvergleich in den Rechtsstreitigkeiten rund um die Arznei Zantac in den USA…

GSK Inks Lupus Deal With Chinese Biotech for Up to $850 Million

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to…

GSK looking to move on from Zantac litigation

GSK PLC (LSE:GSK, NYSE:GSK) share price bump on settlement of most of its Zantac litigation claims has reversed recently on…

GSK Zantac settlement a clear win, say brokers

GSK PLC (LSE:GSK, NYSE:GSK) US$2.2 billion settlement for 93% of Zantac litigation cases is almost a best-case scenario short of no…

GSK: Vergleich in der Zantac-Sache in den USA - Aktiennews

Frankfurt (www.aktiencheck.de) - GSK: Vergleich in der Zantac-Sache in den USA - Aktiennews Die Aktien des britischen Pharmariesen GSK plc (GlaxoSmithKline)…

GSK Aktie: Das ist ein Paukenschlag!

Kulmbach (www.aktiencheck.de) - GSK-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

GSK settles US Zantac lawsuit for $2.2bn

GSK PLC (LSE:GSK, NYSE:GSK) has agreed to pay up to $2.2 billion to settle around 80,000 US lawsuits concerning its heartburn…

GSK: Does RSV jab work too well?

GSK PLCs respiratory syncytial virus (RSV) vaccine, Arexvy, faces challenges that could impact its financial future, according to a report by…

Does GSKs RSV jab work too well?

GSK PLCs respiratory syncytial virus (RSV) vaccine, Arexvy, faces challenges that could impact its financial future, according to a report by…

Does GSKs RSV jab work too well?

GSK PLCs respiratory syncytial virus (RSV) vaccine, Arexvy, faces challenges that could impact its financial future, according to a report by…

GSK cancer drugs fast-tracked by Chinese

GSK PLC (LSE:GSK, NYSE:GSK) announced that its blood cancer drug Blenrep (belantamab mafodotin), in combination with two current treatments, has…

GSK enjoys success with mRNA flu vaccine trial

GSK PLC (LSE:GSK, NYSE:GSK) has been encouraged by the initial results of a seasonal flu vaccine using mRNA technology. Following…

GSK clouds blowing over suggests Berenberg

GSK PLC (LSE:GSK, NYSE:GSK) has been reiterated as a buy at broker Berenberg, which sees some of the ‘clouds of…

GSK herpes vaccine fails in clinical trial

Shares in GSK PLC (LSE:GSK, NYSE:GSK) fell over 1% after the drug maker said it would abandon further trials for…

GSK drug promotes ‘significant and clinically meaningful reduction’ in asthma symptoms

British pharmaceuticals giant GSK PLC (LSE:GSK, NYSE:GSK) has presented late-breaking data at the European Respiratory Society (ERS) International Congress,...…

GSK sees positive COPD trial results

GSK PLC (LSE:GSK, NYSE:GSK) announced positive results from a Phase III clinical trial, MATINEE, evaluating Nucala (mepolizumab) in chronic obstructive...…

GSK: European Union approves label expansion for RSV jab

The European Commission has approved the expanded use of GSK PLC (LSE:GSK, NYSE:GSK)’s Arexvy, its respiratory syncytial virus (RSV) vaccine,…

GSK shares higher after Delaware Zantac ruling

GSK PLC (LSE:GSK, NYSE:GSK) shares opened higher after Delawares Supreme Court said it will hear an appeal by the UK…

GSK wieder im Value-Territorium - Hochstufung! Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft die…

GSK gets fast-track approval from FDA for Chinese lung cancer drug

GSK PLC (LSE:GSK, NYSE:GSK) has received the green light for a speedier US regulatory process for a potential new cancer drug being…

GSK’s discount unwarranted, especially with latest Zantac win, says broker

British pharma multinational GSK PLC (LSE:GSK, NYSE:GSK) has persistently been undervalued against its international peer set due to merited fears…

GSK’s discount unwarranted, especially with latest Zantac win, says broker

British pharma multinational GSK PLC (LSE:GSK, NYSE:GSK) has persistently been undervalued against its international peer set due to merited fears…

GSK wins favourable ruling in US Zantac litigation

GSK PLC (LSE:GSK, NYSE:GSK) has secured a legal victory in the ongoing Zantac (ranitidine) litigation, with the Florida State court…

GSK wins favourable ruling in US Zantac litigation

GSK PLC (LSE:GSK, NYSE:GSK) has secured a legal victory in the ongoing Zantac (ranitidine) litigation, with the Florida State court…

GSK wins Illinois court battle

GSK PLC (LSE:GSK, NYSE:GSK) has successfully refuted claims that its discontinued heartburn drug Zantac caused cancer after an Illinois jury…

GSK wins Illinois Zantac court battle

GSK PLC (LSE:GSK, NYSE:GSK) has successfully refuted claims that its discontinued heartburn drug Zantac caused cancer after an Illinois jury…

GSK cancer drug receives expanded approval from the US regulator

The US Food and Drug Administration (FDA) has expanded the approval of GSK PLC (LSE:GSK, NYSE:GSK)’s Jemperli (dostarlimab) in combination…

GSK sees £1.2bn wiped from its value as investors grumble about vaccine miss

Around £1.2 billion was wiped from the value of GSK PLC (LSE:GSK, NYSE:GSK) after the drug giants Q2 vaccine sales…

GSK: Impfstoffsegment enttäuscht - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

GSK verdient operativ mehr und erhöht Jahresziele - Aktie dennoch im Minus

LONDON (dpa-AFX) - Beim Pharmakonzern GSK laufen die Geschäfte weiterhin rund. Für das Gesamtjahr hob…

GSK forecast upgrade fails to impress the market

GSK PLC (LSE:GSK, NYSE:GSK) has raised its annual earnings and sales forecasts after a strong second-quarter performance driven by cancer…

GSK reaches confidential settlement in Illinois

GSK PLC (LSE:GSK, NYSE:GSK) said it has reached a confidential settlement with Ronald Kimbrow resolving the case he filed in Illinois…

GSKs vaccine receives positive European Medicines Agency opinion

GSK PLCs (LSE:GSK, NYSE:GSK) respiratory syncytial virus vaccine, Arexvy, has received a positive opinion from the European Medicines Agencys Committee...…

Merz will europäische Pharmaindustrie stärken

DRESDEN (dpa-AFX) - Der CDU-Bundesvorsitzende Friedrich Merz will die Wettbewerbsfähigkeit der europäischen Pharmaindustrie stärken. Es brauche…

GSK downgraded by UBS over vaccine concerns, Zantac litigation

UBS analysts have downgraded GSK PLC (LSE:GSK, NYSE:GSK) from a buy to neutral rating, citing uncertainties surrounding its vaccine portfolio and...…

ANALYSE-FLASH: UBS senkt GSK auf 'Neutral' - Ziel runter auf 1580 Pence

ZÜRICH (dpa-AFX) - Die Schweizer Großbank UBS hat GSK von "Buy" auf "Neutral" abgestuft und…

Global Herpes Treatment Market Size To Worth USD 1.87 Billion By 2033 | CAGR Of 4.28%

The Global Herpes Treatment Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Herpes Treatment Market…

GSK takes full control of flu vaccine programme in €1.45bn deal

GSK PLC (LSE:GSK, NYSE:GSK) said it will take effective control of a collaboration to create new mRNA vaccines for influenza and…

GSK and Moderna slide on RSV vaccine CDC updates

GSK PLC (LSE:GSK, NYSE:GSK) shares fell 6% after US authorities recommended restrictions on doses of any respiratory syncytial virus (RSV) vaccine.…

GSK and Moderna RSV vaccine sell-off is overdone, say analysts

After GSK PLC (LSE:GSK, NYSE:GSK) shares fell sharply on the back of US authorities restricting doses of respiratory syncytial virus (RSV)…

GSK plunges as US restricts RSV vaccine

GSK PLC (LSE:GSK, NYSE:GSK) shares plunged close to 7% following a ruling in the US that is likely to restrict…

GSK plunges as US restricts RSV vaccine

GSK PLC (LSE:GSK, NYSE:GSK) shares plunged close to 7% following a ruling in the US that is likely to restrict…

GSK plummets as US restricts RSV vaccine

GSK PLC (LSE:GSK, NYSE:GSK) is attempting to drive the FTSE 100 lower after it plunged close to 7% following a…

GSK 100% backs London listing, says boss

GSK PLC (LSE:GSK, NYSE:GSK) has issued its support to the flagging London market, stating that it is “unequivocally, 100 per cent…